151 related articles for article (PubMed ID: 14551506)
1. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.
Lenz G; Hacker UT; Kern W; Schalhorn A; Hiddemann W
Anticancer Drugs; 2003 Oct; 14(9):731-3. PubMed ID: 14551506
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Bhargava P; Gammon D; McCormick MJ
Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
[No Abstract] [Full Text] [Related]
3. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
4. [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer].
Katayose Y; Nakagawa K; Onogawa T; Yoshida H; Motoi F; Naitoh T; Rikiyama T; Egawa S; Unno M
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2651-3. PubMed ID: 22189236
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
Taylor SE; Beck TL; Krivak TC; Zorn KK; Kelley JL; Edwards RP
Gynecol Oncol; 2014 Jul; 134(1):68-72. PubMed ID: 24769036
[TBL] [Abstract][Full Text] [Related]
8. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.
Shao YY; Hu FC; Liang JT; Chiu WT; Cheng AL; Yang CH
J Formos Med Assoc; 2010 May; 109(5):362-8. PubMed ID: 20497869
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions to oxaliplatin: experience in a single institute.
Siu SW; Chan RT; Au GK
Ann Oncol; 2006 Feb; 17(2):259-61. PubMed ID: 16282245
[TBL] [Abstract][Full Text] [Related]
12. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
[TBL] [Abstract][Full Text] [Related]
13. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
Yoshida Y; Hirata K; Matsuoka H; Iwamoto S; Kotaka M; Fujita H; Aisu N; Hoshino S; Kosaka T; Maeda K; Kiyomi F; Yamashita Y
Drug Des Devel Ther; 2015; 9():6067-73. PubMed ID: 26648694
[TBL] [Abstract][Full Text] [Related]
14. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
Maindrault-Goebel F; André T; Tournigand C; Louvet C; Perez-Staub N; Zeghib N; De Gramont A
Eur J Cancer; 2005 Oct; 41(15):2262-7. PubMed ID: 16154353
[TBL] [Abstract][Full Text] [Related]
15. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.
Lee MY; Yang MH; Liu JH; Yen CC; Lin PC; Teng HW; Wang WS; Chiou TJ; Chen PM
Support Care Cancer; 2007 Jan; 15(1):89-93. PubMed ID: 16865410
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
Zhang X; Zhao Y; Zheng Y; Dong Y
J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
[No Abstract] [Full Text] [Related]
17. Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.
Yanai T; Iwasa S; Hashimoto H; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Yamamoto H
Anticancer Res; 2012 Dec; 32(12):5521-6. PubMed ID: 23225461
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
Hewitt MR; Sun W
Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
Gammon D; Bhargava P; McCormick MJ
Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
